- Home
- ASMB vs USEG Comparison
ASMB vs USEG Comparison
Compare ASMB & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- USEG
- Stock Information
- Founded
- ASMB 2005
- USEG 1966
- Country
- ASMB United States
- USEG United States
- Employees
- ASMB N/A
- USEG N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- USEG Oil & Gas Production
- Sector
- ASMB Health Care
- USEG Energy
- Exchange
- ASMB Nasdaq
- USEG Nasdaq
- Market Cap
- ASMB 198.6M
- USEG 40.5M
- IPO Year
- ASMB 2010
- USEG N/A
- Fundamental
- Price
- ASMB $20.62
- USEG $1.16
- Analyst Decision
- ASMB Strong Buy
- USEG Strong Buy
- Analyst Count
- ASMB 4
- USEG 1
- Target Price
- ASMB $41.33
- USEG $3.50
- AVG Volume (30 Days)
- ASMB 138.4K
- USEG 214.2K
- Earning Date
- ASMB 11-06-2025
- USEG 11-11-2025
- Dividend Yield
- ASMB N/A
- USEG N/A
- EPS Growth
- ASMB N/A
- USEG N/A
- EPS
- ASMB N/A
- USEG N/A
- Revenue
- ASMB $33,247,000.00
- USEG $12,542,000.00
- Revenue This Year
- ASMB $11.57
- USEG N/A
- Revenue Next Year
- ASMB N/A
- USEG $184.02
- P/E Ratio
- ASMB N/A
- USEG N/A
- Revenue Growth
- ASMB 54.77
- USEG N/A
- 52 Week Low
- ASMB $7.75
- USEG $0.92
- 52 Week High
- ASMB $27.17
- USEG $6.40
- Technical
- Relative Strength Index (RSI)
- ASMB 34.76
- USEG 47.34
- Support Level
- ASMB $22.36
- USEG $1.12
- Resistance Level
- ASMB $22.93
- USEG $1.22
- Average True Range (ATR)
- ASMB 1.22
- USEG 0.04
- MACD
- ASMB -0.64
- USEG 0.01
- Stochastic Oscillator
- ASMB 6.60
- USEG 50.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.